Residual Neuromuscular Blockade Clinical Trial
Official title:
Effect of Calcium Chloride on Recovery From Neuromuscular Blockade in Patients Undergoing General Anesthesia
The purpose of this study is to evaluate the effect of calcium chloride against residual neuromuscular blockade at the end of general anesthesia
During general anesthesia, neuromuscular blocking agent is administered to facilitate
endotracheal intubation and the view of operative field. The neuromuscular blockade should
be reversed at the end of anesthesia to recover spontaneous breathing of the patient.
Residual neuromuscular blockade (RNMB) is defined as train of-four ratio < 0.9. RNMB is a
risk factor for postoperative pulmonary complication and increases postoperative mortality.
Neostigmine is acetylcholinesterase inhibitor routinely used at the end of anesthesia to
prevent RNMB. A meta-analysis, however, showed that 40 percent of patients who received
intermediate-acting neuromuscular blocking agent during anesthesia showed RNMB in PACU.
Calcium triggers the release of acetylcholine from the motor nerve terminal and enhances
excitation-contraction coupling in muscle. Increasing calcium concentrations decreased the
sensitivity to dTc and pancuronium in an animal muscle-nerve model. The effect of calcium
chloride on residual neuromuscular blockade is not studied yet.
The purpose of this study is to evaluate the effect of calcium chloride on residual
neuromuscular blockade at the end of general anesthesia
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04619225 -
Cardiac Output and Recovery Time
|
N/A | |
Recruiting |
NCT05992090 -
Neuromuscular Blockade Monitoring Using Kine-myography vs Electromyography.
|
||
Completed |
NCT02146859 -
Predictor of Residual Neuromuscular Blockade in Recovery Room After General Anesthesia
|
||
Completed |
NCT03585400 -
Validation of the REPS Prediction Tool
|
||
Terminated |
NCT01678625 -
Electromyographic Assessment of Onset and Recovery of Neuromuscular Blockade
|
||
Completed |
NCT03417804 -
Incidence of Postoperative Residual Neuromuscular Blockade in Portugal
|
||
Completed |
NCT03111082 -
Incidence of Postoperative Neuromuscular Blockade in Post-Anesthesia Care Unit at Parkland Hospital: Does Size Matter?
|
||
Completed |
NCT04244266 -
Observational Study in Bariatric Surgery
|
||
Completed |
NCT02939911 -
Residual Neuromuscular Blockade in Pediatric Anesthesia
|
||
Completed |
NCT02660398 -
Incidence and Severity of Residual Neuromuscular Blockade
|
Phase 4 | |
Completed |
NCT03920670 -
Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit
|
N/A | |
Completed |
NCT01837498 -
Reversal of Neuromuscular Blockade in Thoracic Surgical Patients
|
||
Completed |
NCT04352127 -
Visual and Electromyography Assessments in Response to Train-of-Four Stimulation of the Ulnar Nerve
|
N/A | |
Completed |
NCT04312256 -
Thumb vs Great Toe Recovery
|
N/A | |
Completed |
NCT04352140 -
Electromyographic and Acceleromyographic Monitoring in Restricted Arm Movement Surgical Setting
|
N/A | |
Withdrawn |
NCT03574337 -
Residual Neuromuscular Blockade in Cardiac Surgery Patients
|
Phase 4 |